<DOC>
	<DOCNO>NCT00386113</DOCNO>
	<brief_summary>Since influenza vaccine normally administer every year frequent change antigenic composition , safety immunogenicity profile adjuvanted influenza vaccine need re-evaluated repeat vaccine administration . In study , subject previously vaccinate Fluarix influenza adjuvanted vaccine , receive booster dose 2006-2007 season 's formulation either Fluarix adjuvanted vaccine .</brief_summary>
	<brief_title>Study Evaluate Reactogenicity Immunogenicity Revaccination With Adjuvanted Influenza Vaccine Elderly</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>The subject must healthy elderly &gt; /= 67 year previously vaccinate Fluarix adjuvanted vaccine . Subjects exclude take/have take chronically high dos immunosuppressant immunemodifying drug within six month vaccination , immunoglobulins blood product within three month vaccination , investigational product within 30 day vaccination , history influenza infection since previous vaccination , subject acute chronic clinically significant disease immunosuppressive/deficient condition , contraindication influenza vaccination</criteria>
	<gender>All</gender>
	<minimum_age>67 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Influenza</keyword>
	<keyword>improve vaccine</keyword>
	<keyword>elderly</keyword>
</DOC>